Coherent Market Insights named knowledge partner for Pharma Pro & Pack Expo 2026

Coherent Market Insights will serve as the official Knowledge Partner for Pharma Pro & Pack Expo 2026 in Hyderabad from July 9-11, bringing pre-event research, live sessions and a post-show whitepaper to India’s pharmaceutical processing and packaging industry. The partnership is designed to give exhibitors, buyers and manufacturers shared market intelligence as the sector faces regulatory change, automation upgrades and capacity expansion.

Why it matters: - The partnership gives India’s pharma processing and packaging sector a structured source of market intelligence before, during and after the expo. - Exhibitors, buyers and manufacturers are expected to use the research to inform procurement, investment and strategic decisions. - The format extends the event’s value beyond the three-day show floor through a post-event whitepaper and wider distribution of insights.

What happened: - Coherent Market Insights announced that it will be the official Knowledge Partner for Pharma Pro & Pack Expo 2026. - Pharma Pro & Pack Expo 2026 runs July 9-11, 2026, at the HITEX Exhibition Centre in Hyderabad, India. - The expo is billed as India’s leading exhibition for pharmaceutical processing and packaging machinery.

The details: - CMI will publish a co-branded report ahead of the event titled "India Pharma Processing & Packaging Machinery Industry Analysis 2026–2033." - The report is intended to cover market size, growth drivers and emerging trends. - On Day 3, CMI will host two back-to-back sessions expected to run 30-40 minutes each. - Abhijeet Kale, Healthcare at Coherent Market Insights, will present the findings from the pre-event report. - Mohit Shrivastava, AVP-Research & Consulting at CMI, will moderate a panel titled "India Pharma 2030: Strategic Roadmap for Processing, Machinery and Manufacturing Excellence." - Panelists will include Tushar Maradwar of Dr. Reddy's Laboratories, Sridhar Surat of Aurobindo Pharma, Siddharth Krishna of Novartis and Ratnakar Satapathy of Ferring Pharmaceuticals. - CMI will curate the discussion flow and key talking points for the panel. - After the expo, CMI plans to publish a co-branded whitepaper summarizing conference insights, regulatory developments and strategic opportunities discussed during the event. - The whitepaper will also capture forward-looking commentary shared by speakers and panelists. - Pharma Pro & Pack Expo brings together manufacturers, machinery solution providers and other industry stakeholders across India’s pharmaceutical manufacturing ecosystem. - CMI says it supports clients in more than 32 countries with 300+ full-time consultants and a global network of domain experts across 24 countries. - CMI is headquartered in India and has a presence in the U.S. and strategic partnerships across the U.K. and Japan.

Between the lines: - The partnership shows how expo organizers are leaning on research firms to add more decision-making value for attendees. - The setup also reflects rising demand for data-backed guidance as Indian pharma manufacturers deal with regulatory shifts, automation spending and capacity planning. - By packaging the research into pre-show, live and post-show formats, CMI is turning a conference role into a longer content cycle. - More information about Pharma Pro & Pack Expo is available on the event website. - More information about Coherent Market Insights is available on its website.

What's next: - CMI will release the pre-event report before the expo opens. - The Day 3 presentation and panel will provide the main public discussion of the report’s findings. - The post-event whitepaper will follow the expo and extend the event’s takeaways to a broader audience. - Organizers and participants will likely use the gathered insights to frame industry priorities heading into 2030 and beyond.